1Hahn RG, Drobin D, Stable L. Volume kinetics of Ringer' s solution in female volunteers. Br J Anaesth, 1997,78,144-148.
2Waitzinger J, Bepperling F, Pabst G, et al. Pharmacokinetics and tolerability of a new hydroxyrthyl starch (HES) specification (HES 130/0.4) specification after single dose infusion of 6% or 10% solution in healthy volunteers.Clin Drug Invest, 1998,16,151-160.
3Waitzinger J, Bepperling F, Pabst G, et al. Hydroxyrthyl starch (HES) 130/ 0.4,a new I-IFS specification. Pharmacokinetics and safety multiple infusion of 10% solution in healthy volunteers. Drug RD,2003,4,149-157.
4William C. Shoemaker. The significance of blood monitoring and fluid resusci- tation in the high risk operation. J Trauma, 2006,77,223-226.
5曾因明主编.危重病医学.第1版.北京:人民卫生出版社,2001.92-93.
6Kondo Y, Nagai H, Kasahara K, et al. The therapeutic effect of hypertonic solutions on the changes in the effective circulating plasma volume in acute necrotizing pancreatitis in rats. Surg Today, 1998,28,1247-1253.
7Duke T, Molyneux EM. Intravenous fluids for seriously ill children: time to reconsider. Lancet, 2005,362 : 1320-1323.
8Cunliffe M. Fluid and electrolyte management in children. Br J Anaesth, 2003,3:1-4.
9Shann F, Germer S. Hyponatraemia associated with pneumonia or bacterial meningitis. Arch Dis Child, 1985,60:963-966.
10Duke T. Fluid management of bacterial meningitis in developing countries. Arch Dis Child,2006,79:181-185.
同被引文献6
1Brandstrup B, Svensen C, Engquist A. Hemorrhage and operation cause a contraction of the extracellular space needing replacement: Evidence and implications A systematic review [J]. Surgery, 2006,139(3) :419-432.
